AstraZeneca Seeks To Block Actavis' Generic Diabetes Drug
By Kira Lerner ( May 30, 2014, 4:40 PM EDT) -- AstraZeneca AB recently filed suit in New Jersey federal court alleging Watson Laboratories Inc. and Actavis Inc.'s attempt to create a generic version of its Onglyza Type 2 diabetes drug infringes its patent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.